Literature DB >> 11311365

Neuronal death and GSK-3beta: a tau fetish?

M P Mattson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11311365     DOI： 10.1016/s0166-2236(00)01838-5

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  6 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

3.  ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegeneration.

Authors:  Mel B Feany
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

4.  SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.

Authors:  Hong-Bin Luo; Yi-Yuan Xia; Xi-Ji Shu; Zan-Chao Liu; Ye Feng; Xing-Hua Liu; Guang Yu; Gang Yin; Yan-Si Xiong; Kuan Zeng; Jun Jiang; Keqiang Ye; Xiao-Chuan Wang; Jian-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

Review 5.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

6.  Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice.

Authors:  Martina Wiedau-Pazos; Eugene Wong; Esther Solomon; Maricela Alarcon; Daniel H Geschwind
Journal:  Neurobiol Aging       Date:  2007-07-02       Impact factor: 4.673
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.